Alzheimer is a debilitating neurodegenerative disease affecting older people. By ScienceBriefss
Promising drug for Alzheimer disease fails in clinical trial - health news

The results of a clinical trial evaluating the effects of the drug solanezumab in preventing Alzheimer symptoms just came in and they are disappointing. Although the drug showed some positive effects, it was ineffective in preventing the characteristic cognitive decline associated with Alzheimer. Solanezumab is developed by the pharmaceutical company Eli Lilly and it targets the formation of amyloid plaques. These are agglomerations of proteins considered to be responsible for Alzheimer. Other studies involving the same drug are ongoing, so there is still hope that some of them will show positive results.

What is Alzheimer disease? Watch the video below to learn!

Read the full story: columbia.edu
Scientific publication: www.nejm.org